表紙
市場調查報告書

藥物發現外包市場:全球行業分析,規模,佔有率,增長,趨勢和預測(2020-2030年)

Drug Discovery Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

出版商 Transparency Market Research 商品編碼 953569
出版日期 內容資訊 英文 218 Pages
商品交期: 最快1-2個工作天內
價格
藥物發現外包市場:全球行業分析,規模,佔有率,增長,趨勢和預測(2020-2030年) Drug Discovery Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
出版日期: 2020年06月11日內容資訊: 英文 218 Pages
簡介

本報告調查了全球藥物發現外包市場,分析了全球市場概況,市場規模,市場影響因素,細分市場和地區市場,並提供了主要公司的概況。

目錄

第1章前言

第2章先決條件和調查方法

第3章執行摘要:全球藥物發現外包市場

  • 全球藥物發現外包市場規模:基於數量/基於價值

第4章市場概述

  • 定義
  • 市場指數
  • 市場動態
    • 促進要因
    • 抑制因子
    • 市場機會
  • 全球藥物發現外包市場規模預測(基於價值)
  • 全球藥物發現外包市場前景

第5章主要見解

  • 重大併購
  • 藥物發現的技術進步
  • 藥物發現過程:概述
  • COVID-19大流行對藥物發現外包行業的影響
  • 外包給CRO的公司概述
  • 概述:綜合藥物發現支持(IDD)外包趨勢,競爭,業務模型偏好,外包項目類型

第6章按服務類型分列的全球藥物發現外包市場分析和預測

  • 簡介
  • 全球藥物發現外包市場份額分析(基於金額):按服務類型劃分
  • 全球藥物發現外包市場規模預測(基於金額):按服務類型劃分
    • 生物服務
    • 化學服務
    • 鉛鑑定和篩選
    • 優化鉛
    • 其他
  • 按服務類型劃分的市場吸引力分析

第7章按藥物類型分析和預測全球藥物發現外包市場

  • 簡介
  • 全球藥物發現外包市場份額分析(基於金額):按藥物類型
  • 按藥物類型劃分的全球藥物發現外包市場規模預測(基於金額)
    • 小分子
    • 聚合物
  • 按藥物類型劃分的市場吸引力分析

第8章全球藥物發現外包市場的分析和預測:按治療領域劃分

  • 簡介
  • 全球藥物發現外包市場份額分析(基於金額):按治療領域劃分
  • 全球藥物發現外包市場規模預測(基於金額):按治療領域劃分
    • 呼吸系統
    • 抗感染
    • 腫瘤科
    • 心血管
    • 胃腸道
    • 中樞神經系統
    • 免疫調節
    • 其他
  • 按藥物類型劃分的市場吸引力分析

第9章按地區分列的全球藥品外包市場分析和預測

  • 市場前景
  • 全球藥物發現外包市場規模預測(基於金額)
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 按地區劃分的市場吸引力分析

第10章北美藥物發現外包市場分析與預測

  • 主要發現
  • 按服務類型劃分的北美藥品外包市場規模預測
    • 生物服務
    • 化學服務
    • 鉛鑑定和篩選
    • 優化鉛
    • 其他
  • 按藥物類型劃分的北美藥物發現外包市場預測
    • 小分子
    • 聚合物
  • 按治療領域預測的北美藥物發現外包市場規模
    • 呼吸系統
    • 抗感染
    • 腫瘤科
    • 心血管
    • 胃腸道
    • 中樞神經系統
    • 免疫調節
    • 其他
  • 按國家劃分的北美藥物發現外包市場預測
    • 美國
    • 加拿大
  • 北美藥品研發外包市場吸引力分析
    • 按服務類型
    • 按藥物類型
    • 按治療區域
    • 按國家

第11章歐洲藥物發現外包市場分析與預測

第12章亞太地區藥物發現外包市場分析與預測

第13章拉丁美洲藥物發現外包市場分析與預測

第14章中東和非洲毒品發現外包市場分析與預測

第15章競爭情況

  • 市場參與者:競爭矩陣(按等級/公司規模劃分)
  • 公司市場佔有率分析
  • 公司簡介
    • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • WuXi AppTec Co., Ltd.
    • Albany Molecular Research Inc. (AMRI)
    • GVK Biosciences Private Limited
    • Sygnature Discovery
    • Pharmaron Beijing Co., Ltd.
    • WuXi Biologics (Cayman), Inc.
    • Domainex Ltd.
    • Thermo Fisher Scientific, Inc.
    • Jubilant Biosys Ltd.
    • Evotec SE
    • Eurofins Discovery
    • GenScript Biotech Corporation
目錄
Product Code: TMRGL1841

Title:
Drug Discovery Outsourcing Market (Service Type: Biological Services, Chemical Services, Lead Identification & Screening, Lead Optimization, and Others; Drug Type: Small Molecules and Large Molecules; Therapeutic Area: Respiratory System, Anti-infective, Oncology, Cardiovascular, Gastrointestinal, Central Nervous System, and Immunomodulation, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030.

Scope of the Report

TMR's report on the global drug discovery outsourcing market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period from 2020 to 2030. The report provides the overall revenue of the global drug discovery outsourcing market from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global drug discovery outsourcing market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global drug discovery outsourcing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global drug discovery outsourcing market.

The report delves into the competition landscape of the global drug discovery outsourcing market. Key players operating in the global drug discovery outsourcing market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global drug discovery outsourcing market report.

Key Questions Answered:

  • What will be the sales revenue generated by drug discovery outsourcing across all regions during the forecast period?
  • What are the key trends in the global drug discovery outsourcing market?
  • What are major drivers, restraints, and opportunities in the global drug discovery outsourcing market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which therapeutic area segment will generate the maximum revenue by 2030 and which service type segment will expand at the fastest CAGR during the forecast period?

Research Objectives and Research Approach

The comprehensive report on the global drug discovery outsourcing market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global drug discovery outsourcing market. It is followed by market introduction, market dynamics, and an overview of the global drug discovery outsourcing market, which includes TMR's analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global drug discovery outsourcing market report highlights USPs, which include key mergers & acquisitions, technological advancements in drug discovery, Drug Discovery Process - an Overview, COVID-19 Pandemics Impact on Drug Discovery Outsourcing Industry, overview of companies outsourcing to CROs, Overview: Integrated Drug Discovery (IDD) outsourcing- trends, competition, business models preferred, type of projects outsourced, and Porter's Five Force Analysis in the global drug discovery outsourcing market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key players in the global drug discovery outsourcing market has been mapped to ascertain the size of the market in terms of value. The forecast presented here assesses the total revenue generated in the global drug discovery outsourcing market. In order to provide an accurate forecast, we initiated by sizing up the current drug discovery outsourcing market with the help of the parent market.

The report analyzes the global drug discovery outsourcing market in terms of service type, drug type, therapeutic area, and region. Key segments under each criteria have been studied at length and the market share of each of these by the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global drug discovery outsourcing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug Discovery Outsourcing Market

4. Market Overview

  • 4.1. Definition
  • 4.2. Market Indicators
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018-2030
  • 4.5. Global Drug Discovery Outsourcing Market Outlook

5. Key Insights

  • 5.1. Key Mergers & Acquisition
  • 5.2. Technological Advancements in Drug Discovery
  • 5.3. Drug Discovery Process - an Overview
  • 5.4. COVID-19 Pandemics Impact on Drug Discovery Outsourcing Industry
  • 5.5. Overview of Companies outsourcing to CROs
  • 5.6. Overview: Integrated Drug Discovery (IDD) outsourcing- trends, competition, business models preferred, type of projects outsourced

6. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Service Type

  • 6.1. Introduction
  • 6.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type
  • 6.3. Global Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018-2030
    • 6.3.1. Biological Services
    • 6.3.2. Chemical Services
    • 6.3.3. Lead Identification & Screening
    • 6.3.4. Lead Optimization
    • 6.3.5. Others
  • 6.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type

7. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Drug Type

  • 7.1. Introduction
  • 7.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type
  • 7.3. Global Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018-2030
    • 7.3.1. Small Molecules
    • 7.3.2. Large Molecules
  • 7.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type

8. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area
  • 8.3. Global Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018-2030
    • 8.3.1. Respiratory System
    • 8.3.2. Anti-infective
    • 8.3.3. Oncology
    • 8.3.4. Cardiovascular
    • 8.3.5. Gastrointestinal
    • 8.3.6. Central Nervous System
    • 8.3.7. Immunomodulation
    • 8.3.8. Others
  • 8.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area

9. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Region

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. Global Drug Discovery Outsourcing Market Value Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa
  • 9.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region

10. North America Drug Discovery Outsourcing Market Analysis and Forecast

  • 10.1. Key Findings
  • 10.2. North America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018-2030
    • 10.2.1. Biological Services
    • 10.2.2. Chemical Services
    • 10.2.3. Lead Identification & Screening
    • 10.2.4. Lead Optimization
    • 10.2.5. Others
  • 10.3. North America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018-2030
    • 10.3.1. Small Molecules
    • 10.3.2. Large Molecules
  • 10.4. North America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018-2030
    • 10.4.1. Respiratory System
    • 10.4.2. Anti-infective
    • 10.4.3. Oncology
    • 10.4.4. Cardiovascular
    • 10.4.5. Gastrointestinal
    • 10.4.6. Central Nervous System
    • 10.4.7. Immunomodulation
    • 10.4.8. Others
  • 10.5. North America Drug Discovery Outsourcing Market Value Forecast, by Country, 2018-2030
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Drug Discovery Outsourcing Market Attractiveness Analysis
    • 10.6.1. By Service Type
    • 10.6.2. By Drug Type
    • 10.6.3. By Therapeutic Area
    • 10.6.4. By Country

11. Europe Drug Discovery Outsourcing Market Analysis and Forecast

  • 11.1. Key Findings
  • 11.2. Europe Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018-2030
    • 11.2.1. Biological Services
    • 11.2.2. Chemical Services
    • 11.2.3. Lead Identification & Screening
    • 11.2.4. Lead Optimization
    • 11.2.5. Others
  • 11.3. Europe Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018-2030
    • 11.3.1. Small Molecules
    • 11.3.2. Large Molecules
  • 11.4. Europe Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018-2030
    • 11.4.1. Respiratory System
    • 11.4.2. Anti-infective
    • 11.4.3. Oncology
    • 11.4.4. Cardiovascular
    • 11.4.5. Gastrointestinal
    • 11.4.6. Central Nervous System
    • 11.4.7. Immunomodulation
    • 11.4.8. Others
  • 11.5. Europe Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018-2030
    • 11.5.1. U.K.
    • 11.5.2. Germany
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Europe Drug Discovery Outsourcing Market Attractiveness Analysis
    • 11.6.1. By Service Type
    • 11.6.2. By Drug Type
    • 11.6.3. By Therapeutic Area
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast

  • 12.1. Key Findings
  • 1.1. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018-2030
    • 12.1.1. Biological Services
    • 12.1.2. Chemical Services
    • 12.1.3. Lead Identification & Screening
    • 12.1.4. Lead Optimization
    • 12.1.5. Others
  • 12.2. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018-2030
    • 12.2.1. Small Molecules
    • 12.2.2. Large Molecules
  • 12.3. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018-2030
    • 12.3.1. Respiratory System
    • 12.3.2. Anti-infective
    • 12.3.3. Oncology
    • 12.3.4. Cardiovascular
    • 12.3.5. Gastrointestinal
    • 12.3.6. Central Nervous System
    • 12.3.7. Immunomodulation
    • 12.3.8. Others
  • 12.4. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018-2030
    • 12.4.1. China
    • 12.4.2. India
    • 12.4.3. Japan
    • 12.4.4. Australia & New Zealand
    • 12.4.5. Rest of Asia Pacific
  • 12.5. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis
    • 12.5.1. By Service Type
    • 12.5.2. By Drug Type
    • 12.5.3. By Therapeutic Area
    • 12.5.4. By Country/Sub-region

13. Latin America Drug Discovery Outsourcing Market Analysis and Forecast

  • 13.1. Key Findings
  • 13.2. Latin America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018-2030
    • 13.2.1. Biological Services
    • 13.2.2. Chemical Services
    • 13.2.3. Lead Identification & Screening
    • 13.2.4. Lead Optimization
    • 13.2.5. Others
  • 13.3. Latin America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018-2030
    • 13.3.1. Small Molecules
    • 13.3.2. Large Molecules
  • 13.4. Latin America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018-2030
    • 13.4.1. Respiratory System
    • 13.4.2. Anti-infective
    • 13.4.3. Oncology
    • 13.4.4. Cardiovascular
    • 13.4.5. Gastrointestinal
    • 13.4.6. Central Nervous System
    • 13.4.7. Immunomodulation
    • 13.4.8. Others
  • 13.5. Latin America Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018-2030
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis
    • 13.6.1. By Service Type
    • 13.6.2. By Drug Type
    • 13.6.3. By Therapeutic Area
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Drug Discovery Outsourcing Market Analysis and Forecast

  • 14.1. Key Findings
  • 14.2. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018-2030
    • 14.2.1. Biological Services
    • 14.2.2. Chemical Services
    • 14.2.3. Lead Identification & Screening
    • 14.2.4. Lead Optimization
    • 14.2.5. Others
  • 14.3. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018-2030
    • 14.3.1. Small Molecules
    • 14.3.2. Large Molecules
  • 14.4. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018-2030
    • 14.4.1. Respiratory System
    • 14.4.2. Anti-infective
    • 14.4.3. Oncology
    • 14.4.4. Cardiovascular
    • 14.4.5. Gastrointestinal
    • 14.4.6. Central Nervous System
    • 14.4.7. Immunomodulation
    • 14.4.8. Others
  • 14.5. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018-2030
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis
    • 14.6.1. By Service Type
    • 14.6.2. By Drug Type
    • 14.6.3. By Therapeutic Area
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2019
  • 15.3. Company Profiles
    • 15.3.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Strategic Overview
      • 15.3.1.5. SWOT Analysis
    • 15.3.2. WuXi AppTec Co., Ltd.
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Strategic Overview
      • 15.3.2.5. SWOT Analysis
    • 15.3.3. Albany Molecular Research Inc. (AMRI)
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Strategic Overview
      • 15.3.3.5. SWOT Analysis
    • 15.3.4. GVK Biosciences Private Limited
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Strategic Overview
      • 15.3.4.5. SWOT Analysis
    • 15.3.5. Sygnature Discovery
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Strategic Overview
      • 15.3.5.5. SWOT Analysis
    • 15.3.6. Pharmaron Beijing Co., Ltd.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Strategic Overview
      • 15.3.6.5. SWOT Analysis
    • 15.3.7. WuXi Biologics (Cayman), Inc.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Strategic Overview
      • 15.3.7.5. SWOT Analysis
    • 15.3.8. Domainex Ltd.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Strategic Overview
      • 15.3.8.5. SWOT Analysis
    • 15.3.9. Thermo Fisher Scientific, Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Strategic Overview
      • 15.3.9.5. SWOT Analysis
    • 15.3.10. Jubilant Biosys Ltd.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Strategic Overview
      • 15.3.10.5. SWOT Analysis
    • 15.3.11. Evotec SE
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Strategic Overview
      • 15.3.11.5. SWOT Analysis
    • 15.3.12. Eurofins Discovery
      • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Strategic Overview
      • 15.3.12.5. SWOT Analysis
    • 15.3.13. GenScript Biotech Corporation
      • 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Strategic Overview
      • 15.3.13.5. SWOT Analysis

List of Tables

  • Table 01: Companies entering into partnerships with CROs for drug discovery
  • Table 02: Integrated Drug Discovery - Key Players
  • Table 03: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018-2030
  • Table 04: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018-2030
  • Table 05: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018-2030
  • Table 06: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 07: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 08: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018-2030
  • Table 09: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018-2030
  • Table 10: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018-2030
  • Table 11: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 12: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018-2030
  • Table 13: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018-2030
  • Table 14: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018-2030
  • Table 15: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 16: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018-2030
  • Table 17: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018-2030
  • Table 18: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018-2030
  • Table 19: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 20: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018-2030
  • Table 21: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018-2030
  • Table 22: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018-2030
  • Table 23: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 24: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018-2030
  • Table 25: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018-2030
  • Table 26: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018-2030

List of Figures

  • Figure 01: Global Drug Discovery Outsourcing Market
  • Figure 02: Global Drug Discovery Outsourcing Market Size (US$ Mn) Forecast, 2018-2030
  • Figure 03: Global Drug Discovery Outsourcing market Value Share, by Service Type, 2020
  • Figure 04: Global Drug Discovery Outsourcing Market Value Share, by Drug Type, 2020
  • Figure 05: Global Drug Discovery Outsourcing Market Value Share, by Therapeutic Area, 2020
  • Figure 06: Global Drug Discovery Outsourcing Market Value Share, by Region, 2020
  • Figure 07: CRO Services Market - Key Mergers and Acquisitions
  • Figure 08: Technological Advancements in Drug Discovery
  • Figure 09: Drug Discovery & Development Process - an Overview
  • Figure 10: Drug Discovery Process - an Overview
  • Figure 11: IDD Trends
  • Figure 12: IDD Business Models
  • Figure 13: IDD- Types of Projects
  • Figure 14: Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
  • Figure 15: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020-2030
  • Figure 16: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biological Services, 2018-2030
  • Figure 17: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chemical Services, 2018-2030
  • Figure 18: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Identification & Screening, 2018-2030
  • Figure 19: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Optimization, 2018-2030
  • Figure 20: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018-2030
  • Figure 21: Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
  • Figure 22: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020-2030
  • Figure 23: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Small Molecules, 2018-2030
  • Figure 24: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Large Molecules, 2018-2030
  • Figure 25: Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
  • Figure 26: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020-2030
  • Figure 27: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Respiratory System, 2018-2030
  • Figure 28: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anti-infective, 2018-2030
  • Figure 29: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oncology, 2018-2030
  • Figure 30: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiovascular, 2018-2030
  • Figure 31: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gastrointestinal, 2018-2030
  • Figure 32: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Central Nervous System, 2018-2030
  • Figure 33: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Immunomodulation, 2018-2030
  • Figure 34: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018-2030
  • Figure 35: Global Drug Discovery Outsourcing Market: Regional Outlook
  • Figure 36: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 37: Global Drug Discovery Outsourcing Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 38: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 39: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 40: North America Drug Discovery Outsourcing Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 41: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 42: North America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
  • Figure 43: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020-2030
  • Figure 44: North America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
  • Figure 45: North America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020-2030
  • Figure 46: North America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
  • Figure 47: North America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020-2030
  • Figure 48: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 49: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 50: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 51: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
  • Figure 52: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020-2030
  • Figure 53: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
  • Figure 54: Europe Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020-2030
  • Figure 55: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
  • Figure 56: Europe Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020-2030
  • Figure 57: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 58: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 59: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 60: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
  • Figure 61: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020-2030
  • Figure 62: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
  • Figure 63: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020-2030
  • Figure 64: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
  • Figure 65: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020-2030
  • Figure 66: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 67: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 68: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 69: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
  • Figure 70: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020-2030
  • Figure 71: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
  • Figure 72: Latin America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020-2030
  • Figure 73: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
  • Figure 74: Latin America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020-2030
  • Figure 75: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 76: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 77: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 78: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
  • Figure 79: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020-2030
  • Figure 80: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
  • Figure 81: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020-2030
  • Figure 82: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
  • Figure 83: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020-2030
  • Figure 84: Global Drug Discovery Outsourcing Market Analysis, by Top Company Ranking, 2019